Tushar Makhija
ASA
Associate Actuary
Atlanta, GA, US
Tushar Makhija is an associate actuary with the Atlanta office of Milliman. He joined the firm in 2017.
Experience
Tushar has consulted with health insurance companies, PSHPs, Blue Cross and Blue Shield plans, and pharmaceutical manufacturers while at Milliman. Prior to joining Milliman, he worked for another consulting firm supporting various aspects of life insurance actuarial work.
Types of actuarial support Tushar has provided for his clients include:
- Pricing and rate development for Medicare Advantage products
- Estimation of actuarial liabilities/assets for financial reporting and annual statement year-end support
- Financial forecasting and trend development for health plans
- Healthcare cost analytics and actuarial cost model development for use in benchmarking or performance analysis using CMS 100% RIF data
- Estimation of Medicare Part D funding parameters in a post-IRA world
Professional Designations
- Associate of the Society of Actuaries
- Member of the American Academy of Actuaries
Education
- MS, Mathematics, Florida State University
Publications
Read their latest work
Article
Financial implications of the Inflation Reduction Act are expected to lead to a reassessment of formulary strategies by Part D plans
21 December 2023 - by Jennifer Carioto, Gabriela Dieguez, Tushar Makhija
We expect the financial implications of the Inflation Reduction Act to lead to a reassessment of formulary strategies by Medicare Part D plans.
Article
Medicare Advantage organizations financial results for 2022
17 November 2023 - by Phil Ellenberg, Shyam Kolli, Tushar Makhija, Greg Sgrosso
We summarize the 2022 numbers for MAOs reporting Medicare Advantage experience under the Title XVIII line on the NAIC annual statement.
Article
A primer on Medicare Part D prescription drug rebates: Insights into the possible impact of the Inflation Reduction Act
29 September 2023 - by Jennifer Carioto, Tushar Makhija, Maggie Alston
We offer a primer on the Medicare Part D prescription drug rebates, with insights into the possible impact of the Inflation Reduction Act.
Article
Medicare Advantage organizations financial results for 2021
01 December 2022 - by Phil Ellenberg, Shyam Kolli, Tushar Makhija, Greg Sgrosso
We summarize the 2021 numbers for organizations reporting Medicare Advantage experience under the Title XVIII line on the NAIC annual statement.
Article
Medicare Advantage Organizations financial results for 2020
07 March 2022 - by Phil Ellenberg, Shyam Kolli, Tushar Makhija, Greg Sgrosso
We analyze information from 374 Medicare Advantage organizations across 43 states, with the data revealing the majority of them profitable.
Article
Medicare Advantage financial results for 2019: December 2020
04 January 2021 - by Phil Ellenberg, Shyam Kolli, Tushar Makhija, Greg Sgrosso
This report summarizes the CY 2019 experience of selected financial metrics of organizations reporting Medicare experience under the Title XVIII Medicare line of business on the National Association of Insurance Commissioners Annual Statement.